SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NNVC - NanoViricides, Inc.
NNVC 1.1900.0%Dec 26 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Magnus1 who wrote (10946)8/21/2018 11:45:21 PM
From: BoredMember1 Recommendation

Recommended By
HardToFind

  Read Replies (1) of 12873
 
Theracour owns all the IP, including manufacturing process, scale up, and andnother “trade secrets” developed and created by their employees. NNVC does not have any lab techs on their payroll. That is how Dr. Anil made it certain that even if Nanoviricides were acquired, he would still own and control all the “IP” as you call it.

Sorry.

Wow, this is a pretty complex concept for me!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News